AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Merck & Co., Inc., Rahway, NJ, USA (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,033
total citations
- FWCI
- 26.55
- Percentile
- 100%
- References
- 83
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- AMPK
- Diabetes mellitus
- Metabolic syndrome
- Drug
- Medicine
- Metformin
- Drug discovery
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.